US donates $1 billion to Oxford University’s COVID-19 vaccine in exchange for 300 million doses
June 1, 2020Sales and Marketing COVID-19, coronavirus
The US has given $1 billion to AstraZeneca to advance the development and production of the vaccine they are creating …
First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment
May 29, 2020Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir
The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …
Leukaemia drug nilotinib shows promise against Alzheimer’s in small clinical study
May 29, 2020Medical Communications Alzheimer's, leukaemia
The leukemia drug nilotinib has shown promise in reducing the effects of Alzheimer’s disease and while having safe and minimal …
Top Ten most popular articles on Pharmafile.com this week
May 29, 2020Medical Communications COVID-19, coronavirus, top 10
GlaxoSmithKline features prominently in the news this week, as they pledged to pay a cash bonus of £1,500 to staff …
MSD and Eisai announce meaningful objective response rates for Keytruda+Lenvima combo in two cancer patient populations
May 29, 2020Medical Communications, Research and Development Lenvima, keytruda, pharma
MSD has pulled back the curtain on new data from two trials of its anti-PD-1 immunotherapy Keytruda (pemvbrolizmuab) in combination …
FDA advises recall of diabetes drug metformin over carcinogen concerns
May 29, 2020Medical Communications Carcinogens, MDMA
The FDA has asked that multiple pharmaceutical companies recall the formulations of their diabetes drug metformin after the regulatory body …
GlaxoSmithKline commits to the production of one billion doses of COVID-19 vaccine adjuvant in 2021
May 28, 2020Manufacturing and Production COVID-19, GSK, coronavirus, pharma, vaccines
GlaxoSmithKline has just come forward to commit to the manufacture and distribution of one billion doses of vaccine adjuvant against …
Novartis releases results of MS drug trials weeks ahead of FDA verdict
May 28, 2020Business Services MS, Novartis
Novartis has revealed clinical trial data from testing its anti-CD20 leukameia drug Arzerra (ofatumumab) in patients with multiple sclerosis (MS). …
BMS’ Zeposia becomes first S1P receptor modulator available in Europe for relapsing remitting multiple sclerosis
May 28, 2020Sales and Marketing Avonex, Bristol-Myers Squibb, EU, Europe, Zeposia, bristol myers squibb, multiple sclerosis
Bristol Myers Squibb is celebrating after its oral therapy Zeposia (ozanimod), secured European Commission for the treatment of relapsing remitting …
European countries reject hydroxychloroquine treatments for COVID-19
May 28, 2020Business Services COVID-19, coronavirus, hydroxychloroquine
Multiple European countries have rejected the use of hydroxychloroquine in patients suffering from coronavirus, due to a lack of evidence …
FDA grants marketing approval for US Army’s malaria treatment
May 28, 2020Business Services Malaria drug, US, US army, US., malaria
The FDA has granted marketing approval for the US Army Medical Research and Development Command’s (USAMRDC) Artesunate for injection, which …
Evox appoints ex-GSK exec Martin Andrews as new non-Executive Director
May 28, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evox, GSK, appointment
Evox Therapeutics has named ex-GlaxoSmithKline executive Martin Andrews as its new non-Executive Director, it has emerged. Andrews has previously …
Axim Biotechnologies Inc announces Dr Sergei Svarovsky as Chief Scientific Officer of subsidiary Sapphire Biotech
May 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Axim Biotechnologies has announced that Dr Sergei Svarovsky will be the new Chief Scientific Officer of its subsidiary Sapphire Biotech. …
FDA approves Sanofi’s Dupixent for children with dermatitis
May 27, 2020Research and Development Dupixent, Sanofi, atopic eczema
The FDA has approved Sanofi’s Dupixent (dupilumab) for children between ages 6 to 11 with moderate to severe atopic dermatitis. …
The June 2020 issue of Pharmafocus is available to read free online now!
May 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, coronavirus, data management, pharma, rare disease, treatment access
The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …
Pharmafile.com’s weekly COVID-19 news round-up
May 27, 2020Research and Development COVID-19, coronavirus, coronavirus round up
COVID-19 vaccines and treatments continue to dominate the news, as AstraZeneca is attempting to deliver one billion doses of coronavirus …
NICE reverses previous stance to recommend Roche’s Tecentriq in extensive-stage small-cell lung cancer
May 27, 2020Research and Development, Sales and Marketing NICE, Roche, lung cancer, tecentriq
NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new …
Remdesivir available to select COVID-19 patients through the NHS
May 27, 2020Research and Development coronavirus, covid19
Gilead Sciences Ebola drug remdesivir will be available for selected patients who are suffering from coronavirus through the NHS. The …
Living with multiple ‘invisible’ conditions
May 26, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, rare disease
Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …
Scientists working on UK COVID-19 vaccine say there is now only a 50% chance of success due to falling cases
May 26, 2020Manufacturing and Production COVID-19, coronavirus
Researchers working on a COVID-19 vaccine are facing a race against time due to falling rates of the virus threatening …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
